Hyperimmunized patients awaiting cadaveric kidney graft: Is there a quick desensitization possible?

被引:1
|
作者
Faenza, A. [1 ]
Fuga, G. [1 ]
Bertelli, R. [1 ]
Scolari, M. P. [2 ]
Buscaroli, A. [2 ]
Stefoni, S. [2 ]
机构
[1] S Orsola Univ Hosp, Dept Kidney Transplant Surg & Nephrol, Bologna, Italy
[2] S Orsola Univ Hosp, Dept Dialysis & Transplantat, Bologna, Italy
关键词
D O I
10.1016/j.transproceed.2008.05.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
On all kidney waiting lists the 10% to 20% of patients who have antibodies against more than 80% of a panel of HLA antigens (panel reactive antibody [PRA] > 80%) are difficult to transplant. The best solution for these patients is to find a compatible donor, ideally a full match, who yields a negative crossmatch test (CMX). If this is not possible, desensitization treatment (high-dose) intravenous immunoglobulin (IVIG) or plasmapheresis (PP) + low-dose IVIG is possible with good results in living donor kidney transplantation mainly if the antibody titer is low. It may also be offered to patients awaiting cadaveric donors too after a long waiting time; however, when applied for several months, it has the obvious disadvantage of giving the patient the risk for long-lasting immunologic weakness without the certitude of finding a kidney. In one of our recent cases of combined liver plus kidney transplantation, a positive CMX became negative 8 hours after the liver operation; the kidney was transplanted with a good result which lasted over 3 years. This observation Suggested the possibility of a quick desensitization protocol in selected patients with a large (but not strong) immunization who probably are the majority. Patients sensitized to IVIG and with low titer PRA could be given a single PP + low-dose IVIG (what can be done within the time limit of cadaveric donor kidney transplantation) with good probability of turning an initial positive CMX to negative with the possibility of performing the operation and the advantage of giving the immunosuppression only when the kidney is present.
引用
收藏
页码:1833 / 1838
页数:6
相关论文
共 50 条
  • [21] HOME HEMODIALYSIS FOR PATIENTS AWAITING A CADAVERIC RENAL-ALLOGRAFT
    JEREMY, D
    JOHNSON, JR
    CATTRAN, DC
    STEWART, JH
    HAYES, JM
    MAHONY, J
    MANI, MK
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1972, 2 (01): : 106 - &
  • [22] SEX DIFFERENCES IN DESENSITIZATION FOR PATIENTS AWAITING HEART TRANSPLANTATION: IS THERE A DIFFERENCE?
    Yamamoto, N.
    Patel, N.
    Singer-Englar, T.
    Kim, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 154 - 155
  • [23] HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival
    Wu, H. -H.
    Tien, Y. -C.
    Huang, C. I.
    Chiang, Y. -J.
    Chu, S. -H.
    Lai, P. -C.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2191 - 2194
  • [24] METABOLIC DISORDERS IN CADAVERIC KIDNEY DONORS AND INITIAL NONFUNCTION OF THE KIDNEY GRAFT
    TEPLAN, V
    SCHUECK, O
    NADVORNIKOVA, H
    KOCANDRLE, V
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (05) : 2619 - 2619
  • [25] Delayed graft function after cadaveric kidney transplantation
    Cheng, WSW
    Pleass, H
    Akyol, M
    Forsythe, JLR
    Madhavan, KK
    Garden, OJ
    BRITISH JOURNAL OF SURGERY, 2002, 89 : 34 - 34
  • [26] MICA antibodies in patients awaiting a renal graft
    Cook, E.
    Darke, C.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (06) : 495 - 495
  • [27] Drug regimens affect cadaveric kidney graft survival
    Kauffman, HM
    Cherikh, WS
    Delmonico, FL
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1029 - 1030
  • [28] SURGICAL DAMAGE TO CADAVERIC KIDNEY GRAFT DURING PROCUREMENT
    MICHEL, F
    GATTEGNO, B
    SCETBON, V
    ANSQUER, JC
    THIBAULT, P
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (01) : 288 - 289
  • [29] Use of IVIG plus single dose rituximab for desensitization of highly-HLA sensitized patients awaiting kidney transplantation
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 181 - 181
  • [30] Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France
    Annaë Liu
    Mélisande Bernard
    BioDrugs, 2014, 28 : 55 - 61